10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001439222-22-000099`
Period End Date	20220930
Filing Date	20221103
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	agio-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 84 Cash Flow Statement 88 Stockholders Equity 51 Comprehensive Income 16

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$122.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$203.13M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$816.89M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$605.23M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	-	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$1.82M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$4.38M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$3.77M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	70.55M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	71.11M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Inventory	`InventoryNet`	$5.18M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.84M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$46.49M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	54.89M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	54.33M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$784.93M	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	16.22M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	16.22M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.06B	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$266.38M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$298.35M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$75.12M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$67.69M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$25.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.92M	USD	Point-in-time
Financing lease assets	`FinanceLeaseRightOfUseAsset`	-	USD	Point-in-time
Financing lease assets	`FinanceLeaseRightOfUseAsset`	$183.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.90M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.90M	USD	Point-in-time
Total assets	`Assets`	$1.44B	USD	Point-in-time
Total assets	`Assets`	$1.18B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.41M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.97M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$29.76M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$13.34M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.83M	USD	Point-in-time
Financing lease liabilities	`FinanceLeaseLiabilityCurrent`	$331.00K	USD	Point-in-time
Financing lease liabilities	`FinanceLeaseLiabilityCurrent`	$83.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$53.60M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$75.50M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$85.66M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.05M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$276.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$145.76M	USD	Point-in-time
Total liabilities	`Liabilities`	$130.15M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,110,442 shares issued and 54,894,031 shares outstanding at September 30, 2022, and 70,550,631 shares issued and 54,334,220 shares outstanding at December 31, 2021	`CommonStockValueOutstanding`	$71.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,110,442 shares issued and 54,894,031 shares outstanding at September 30, 2022, and 70,550,631 shares issued and 54,334,220 shares outstanding at December 31, 2021	`CommonStockValueOutstanding`	$71.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.37B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.33B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-15.08M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2022 and December 31, 2021)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2022 and December 31, 2021)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-507.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-238.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.39B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.05B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.30B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.72B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.12B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$399.50M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.44B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.18B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.52M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$9.93M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$517.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.29M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	-	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$64.97M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$183.67M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$209.61M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$64.00M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$89.92M	USD	3 Qtrs
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$27.15M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$29.12M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$88.90M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$91.15M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$94.61M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$273.59M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$299.81M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-273.59M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-91.09M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-289.88M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-91.15M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$9.85M	USD	3 Qtrs
Royalty income from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$4.00M	USD	3 Qtrs
Royalty income from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$2.00M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$4.44M	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$256.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$6.30M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeNet`	$3.82M	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$504.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$11.16M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.08M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$4.64M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$5.39M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-84.26M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-268.33M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-257.93M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-81.75M	USD	1 Quarter
Net (loss) income from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	3 Qtrs
Net (loss) income from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Net (loss) income from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-4.51M	USD	1 Quarter
Net (loss) income from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.96B	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.75M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-268.33M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$1.70B	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-88.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.49	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.48	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-4.90	USD	3 Qtrs
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-4.13	USD	3 Qtrs
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.48	USD	1 Quarter
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-4.13	USD	3 Qtrs
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.49	USD	1 Quarter
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-4.90	USD	3 Qtrs
Net (loss) income from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net (loss) income from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$31.31	USD	3 Qtrs
Net (loss) income from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.08	USD	1 Quarter
Net (loss) income from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Net (loss) income from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Net (loss) income from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.08	USD	1 Quarter
Net (loss) income from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Net (loss) income from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$31.31	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.49	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-4.90	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$27.19	USD	3 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.56	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$27.19	USD	3 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.56	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.49	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-4.90	USD	3 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	62.50M	shares	3 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.73M	shares	3 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	57.05M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.84M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	62.50M	shares	3 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.84M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.05M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.73M	shares	3 Qtrs

Cash Flow Statement 88 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.75M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-268.33M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$1.70B	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-88.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Less: Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	3 Qtrs
Less: Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Less: Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-4.51M	USD	1 Quarter
Less: Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.96B	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-84.26M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-268.33M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-257.93M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-81.75M	USD	1 Quarter
Depreciation and amortization	`OtherDepreciationAndAmortization`	$6.75M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$7.04M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$41.89M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$37.83M	USD	3 Qtrs
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-721.00K	USD	3 Qtrs
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.33M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-9.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-29.00K	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$7.43M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$7.13M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInContractWithCustomerAsset`	$1.82M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInContractWithCustomerAsset`	-	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$5.18M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$6.99M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-604.00K	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$19.25M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.66M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.34M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.63M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.21M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.67M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-7.65M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-5.32M	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$779.00K	USD	3 Qtrs
Net cash used in operating activities - continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-234.09M	USD	3 Qtrs
Net cash used in operating activities - continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-243.31M	USD	3 Qtrs
Net cash used in operating activities - discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash used in operating activities - discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-89.13M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-323.23M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-243.31M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$782.22M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$951.41M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$947.30M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$492.91M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.77M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.24M	USD	3 Qtrs
Net cash provided by (used in) investing activities - continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$160.31M	USD	3 Qtrs
Net cash provided by (used in) investing activities - continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-459.74M	USD	3 Qtrs
Net cash provided by investing activities - discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by investing activities - discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$1.80B	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.34B	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$160.31M	USD	3 Qtrs
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$248.00K	USD	3 Qtrs
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$773.00K	USD	3 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$783.44M	USD	3 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.58M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$37.03M	USD	3 Qtrs
Net cash provided by (used in) financing activities - continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.33M	USD	3 Qtrs
Net cash provided by (used in) financing activities - continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-747.18M	USD	3 Qtrs
Net cash provided by financing activities - discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by financing activities - discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-747.18M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.33M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-80.68M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$272.79M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.45M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$400.22M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$122.45M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$400.22M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$21.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$486.00K	USD	3 Qtrs
Financing lease liabilities arising from obtaining financing lease assets	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	-	USD	3 Qtrs
Financing lease liabilities arising from obtaining financing lease assets	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	$511.00K	USD	3 Qtrs
Cash taxes paid	`IncomeTaxesPaidNet`	$1.94M	USD	3 Qtrs
Cash taxes paid	`IncomeTaxesPaidNet`	$8.92M	USD	3 Qtrs

Stockholders Equity 51 line items

Line Item	Tag	Value	Unit	Period
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	54.89M	shares	Point-in-time
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	54.33M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$1.39B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.05B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.30B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.72B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.12B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$399.50M	USD	Point-in-time
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	5,476.00	shares	3 Qtrs
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.29M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.35M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$15.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.27M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$25.67M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.01M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.51M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.16M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.85M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.88M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.16M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.15M	USD	1 Quarter
Repurchase of common stock	`TreasuryStockValueAcquiredCostMethod`	$529.05M	USD	1 Quarter
Repurchase of common stock	`TreasuryStockValueAcquiredCostMethod`	$254.39M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-141.00K	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-6.55M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-54.00K	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-108.00K	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-2.76M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-4.58M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.75M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-268.33M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$1.70B	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-88.77M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-712.00K	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-33.00K	USD	1 Quarter
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	54.89M	shares	Point-in-time
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	54.33M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$1.39B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.05B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.30B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.72B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.12B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$399.50M	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-81.75M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-268.33M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$1.70B	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-88.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-303.00K	USD	3 Qtrs
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-13.88M	USD	3 Qtrs
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-54.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.58M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$1.70B	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-88.82M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-282.21M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-86.33M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.